NVO logo

Novo Nordisk A/S (NVO) Current liabilities

annual current liabilities:

$30.21B+$5.07B(+20.15%)
December 31, 2024

Summary

  • As of today (August 20, 2025), NVO annual total current liabilities is $30.21 billion, with the most recent change of +$5.07 billion (+20.15%) on December 31, 2024.
  • During the last 3 years, NVO annual current liabilities has risen by +$14.99 billion (+98.51%).
  • NVO annual current liabilities is now at all-time high.

Performance

NVO Current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVObalance sheet metrics

quarterly current liabilities:

$32.65B-$1.54B(-4.49%)
June 1, 2025

Summary

  • As of today (August 20, 2025), NVO quarterly total current liabilities is $32.65 billion, with the most recent change of -$1.54 billion (-4.49%) on June 1, 2025.
  • Over the past year, NVO quarterly current liabilities has increased by +$5.65 billion (+20.90%).
  • NVO quarterly current liabilities is now -4.49% below its all-time high of $34.19 billion, reached on March 31, 2025.

Performance

NVO quarterly current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVObalance sheet metrics

Current liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

NVO Current liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+20.1%+20.9%
3 y3 years+98.5%+111.8%
5 y5 years+240.9%+222.0%

NVO Current liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+98.5%-4.5%+111.8%
5 y5-yearat high+240.9%-4.5%+222.0%
alltimeall timeat high>+9999.0%-4.5%>+9999.0%

NVO Current liabilities History

DateAnnualQuarterly
Jun 2025
-
$32.65B(-4.5%)
Mar 2025
-
$34.19B(+13.2%)
Dec 2024
$30.21B(+20.1%)
$30.21B(-3.2%)
Sep 2024
-
$31.19B(+15.5%)
Jun 2024
-
$27.01B(+12.6%)
Mar 2024
-
$23.98B(-4.6%)
Dec 2023
$25.14B(+44.8%)
$25.14B(+2.6%)
Sep 2023
-
$24.50B(+6.8%)
Jun 2023
-
$22.95B(+19.2%)
Mar 2023
-
$19.25B(+10.9%)
Dec 2022
$17.36B(+14.1%)
$17.36B(+1.1%)
Sep 2022
-
$17.16B(+11.3%)
Jun 2022
-
$15.42B(+7.8%)
Mar 2022
-
$14.30B(-6.0%)
Dec 2021
$15.22B(+31.7%)
$15.22B(+10.5%)
Sep 2021
-
$13.77B(+18.6%)
Jun 2021
-
$11.61B(+1.5%)
Mar 2021
-
$11.44B(-1.0%)
Dec 2020
$11.55B(+30.4%)
$11.55B(+3.4%)
Sep 2020
-
$11.18B(+10.2%)
Jun 2020
-
$10.14B(+9.1%)
Mar 2020
-
$9.29B(+4.9%)
Dec 2019
$8.86B(+6.8%)
$8.86B(-3.8%)
Sep 2019
-
$9.21B(+6.7%)
Jun 2019
-
$8.64B(+4.8%)
Mar 2019
-
$8.24B(-0.7%)
Dec 2018
$8.30B(+9.3%)
$8.30B(+7.8%)
Sep 2018
-
$7.70B(-0.1%)
Jun 2018
-
$7.71B(+5.8%)
Mar 2018
-
$7.29B(-4.0%)
Dec 2017
$7.59B(+12.8%)
$7.59B(+5.9%)
Sep 2017
-
$7.17B(+6.6%)
Jun 2017
-
$6.72B(-4.4%)
Mar 2017
-
$7.03B(+4.5%)
Dec 2016
$6.73B(+13.1%)
$6.73B(+7.2%)
Sep 2016
-
$6.28B(+1.2%)
Jun 2016
-
$6.20B(-1.3%)
Mar 2016
-
$6.28B(+5.6%)
Dec 2015
$5.95B(+8.7%)
$5.95B(+3.2%)
Sep 2015
-
$5.76B(-0.0%)
Jun 2015
-
$5.76B(-4.5%)
Mar 2015
-
$6.04B(+10.3%)
Dec 2014
$5.47B(+22.4%)
$5.47B(+7.4%)
Sep 2014
-
$5.10B(+16.9%)
Jun 2014
-
$4.36B(-10.5%)
Mar 2014
-
$4.87B(+8.9%)
Dec 2013
$4.47B(+17.0%)
$4.47B(-3.9%)
Sep 2013
-
$4.66B(+5.1%)
Jun 2013
-
$4.43B(+0.4%)
Mar 2013
-
$4.41B(+15.4%)
Dec 2012
$3.82B(+5.4%)
$3.82B(-15.5%)
Sep 2012
-
$4.53B(+11.2%)
Jun 2012
-
$4.07B(+3.4%)
Mar 2012
-
$3.94B(+8.5%)
Dec 2011
$3.63B
$3.63B(-1.1%)
DateAnnualQuarterly
Sep 2011
-
$3.67B(+1.5%)
Jun 2011
-
$3.62B(+4.1%)
Mar 2011
-
$3.47B(+4.4%)
Dec 2010
$3.33B(+28.6%)
$3.33B(+7.2%)
Sep 2010
-
$3.10B(+3.1%)
Jun 2010
-
$3.01B(+6.6%)
Mar 2010
-
$2.82B(+9.1%)
Dec 2009
$2.59B(+6.9%)
$2.59B(+1.8%)
Sep 2009
-
$2.54B(+8.1%)
Jun 2009
-
$2.35B(-6.8%)
Mar 2009
-
$2.52B(+4.2%)
Dec 2008
$2.42B(+16.0%)
$2.42B(+4.4%)
Sep 2008
-
$2.32B(-0.5%)
Jun 2008
-
$2.33B(-5.5%)
Mar 2008
-
$2.46B(+18.1%)
Dec 2007
$2.09B(+16.1%)
$2.09B(+1.6%)
Sep 2007
-
$2.05B(+7.3%)
Jun 2007
-
$1.91B(+0.6%)
Mar 2007
-
$1.90B(+5.9%)
Dec 2006
$1.80B(+7.4%)
$1.80B(-7.9%)
Sep 2006
-
$1.95B(+11.4%)
Jun 2006
-
$1.75B(+2.8%)
Mar 2006
-
$1.70B(+1.8%)
Dec 2005
$1.67B(+25.8%)
$1.67B(+11.1%)
Sep 2005
-
$1.51B(+3.6%)
Jun 2005
-
$1.45B(+11.9%)
Mar 2005
-
$1.30B(-2.4%)
Dec 2004
$1.33B(+15.1%)
$1.33B(+9.6%)
Sep 2004
-
$1.21B(+11.0%)
Jun 2004
-
$1.09B(-5.2%)
Mar 2004
-
$1.15B(-0.2%)
Dec 2003
$1.16B(+37.0%)
$1.16B(+37.0%)
Dec 2002
$843.27M(+17.2%)
$843.27M(+17.2%)
Dec 2001
$719.25M(-10.8%)
$719.25M(-10.8%)
Dec 2000
$806.55M(-8.7%)
$806.55M(+5.9%)
Dec 1999
$883.44M(+2.5%)
$761.33M(-11.4%)
Dec 1998
$861.97M(+11.4%)
$858.95M(+10.2%)
Dec 1997
$773.72M(-6.8%)
$779.56M(-5.6%)
Dec 1996
$830.15M(-1.4%)
$825.71M(+16.4%)
Dec 1995
$841.75M(+11.8%)
$709.25M(-5.8%)
Dec 1994
$752.77M(+38.8%)
$752.74M(+38.1%)
Dec 1993
$542.28M(-0.9%)
$545.20M(-0.4%)
Dec 1992
$547.26M(-16.1%)
$547.28M(-16.1%)
Dec 1991
$652.04M(-9.6%)
$652.11M(-9.5%)
Dec 1990
$721.22M(+30.3%)
$720.85M(+30.8%)
Dec 1989
$553.47M(+39.9%)
$551.25M(+39.1%)
Dec 1988
$395.54M(+14.5%)
$396.36M(+14.2%)
Dec 1987
$345.40M(+15.6%)
$347.05M(+16.2%)
Dec 1986
$298.70M(+67.1%)
$298.79M(+67.2%)
Dec 1985
$178.77M(+7.9%)
$178.69M(+7.8%)
Dec 1984
$165.74M(+18.5%)
$165.83M
Dec 1983
$139.89M(+12.8%)
-
Dec 1982
$124.06M(+14.4%)
-
Dec 1981
$108.43M(+12.1%)
-
Dec 1980
$96.69M
-

FAQ

  • What is Novo Nordisk A/S annual total current liabilities?
  • What is the all time high annual current liabilities for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual current liabilities year-on-year change?
  • What is Novo Nordisk A/S quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly current liabilities year-on-year change?

What is Novo Nordisk A/S annual total current liabilities?

The current annual current liabilities of NVO is $30.21B

What is the all time high annual current liabilities for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual total current liabilities is $30.21B

What is Novo Nordisk A/S annual current liabilities year-on-year change?

Over the past year, NVO annual total current liabilities has changed by +$5.07B (+20.15%)

What is Novo Nordisk A/S quarterly total current liabilities?

The current quarterly current liabilities of NVO is $32.65B

What is the all time high quarterly current liabilities for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly total current liabilities is $34.19B

What is Novo Nordisk A/S quarterly current liabilities year-on-year change?

Over the past year, NVO quarterly total current liabilities has changed by +$5.65B (+20.90%)
On this page